NCT04989218 2024-11-05
ICC
University of Alabama at Birmingham
Phase 1/2 Terminated
Clinical Trials
10 trialsNCT03116529 2024-11-04
NEXIS
University of Maryland, Baltimore
Phase 1/2 Terminated
NCT03370861 2024-09-05
MINING
Washington University School of Medicine
Terminated
NCT06084676 2024-07-17
Organoid Model Predictive of Response to Immunotherapies
Indiana University
Terminated
NCT02949843 2024-06-28
Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations
Wake Forest University Health Sciences
Phase 2 Terminated
NCT02054520 2023-04-18
Immunotherapy Study for Patients With Stage IV Melanoma
Lumos Pharma
Phase 2 Terminated
NCT04653389 2022-01-11
Perioperative Therapy for Hepatocellular Carcinoma
Zhejiang University
Phase 2 Terminated
NCT03115801 2021-09-22
A Phase II Randomized Trial of Immunotherapy Plus Radiotherapy in Metastatic Genitourinary Cancers
Weill Medical College of Cornell University
Phase 2 Terminated
NCT03634800 2021-08-05
RISE-M
Weill Medical College of Cornell University
Phase 2 Terminated
NCT00089856 2008-11-05
GVAX® Vaccine for Prostate Cancer vs Docetaxel & Prednisone in Patients With Metastatic Hormone-Refractory Prostate Cancer
Cell Genesys
Phase 3 Terminated